Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.89K Buy
538
+420
+356% +$4.76K ﹤0.01% 1789
2026
Q2
$1.06K Hold
118
– – ﹤0.01% 2287
2026
Q1
$1.1K Sell
118
-55
-32% -$541 ﹤0.01% 2244
2025
Q4
$1.21K Buy
173
+61
+54% +$384 ﹤0.01% 2248
2025
Q3
$640 Sell
112
-11,862
-99% -$63.3K ﹤0.01% 2389
2025
Q2
$57.2K Buy
11,974
+7,724
+182% +$44.3K ﹤0.01% 1345
2025
Q1
$36.8K Buy
4,250
+305
+8% +$3.2K ﹤0.01% 1492
2024
Q4
$47.9K Buy
3,945
+2,810
+248% +$39.3K ﹤0.01% 1321
2024
Q3
$17.7K Buy
1,135
+464
+69% +$7.64K ﹤0.01% 1989
2024
Q2
$10.6K Buy
671
+559
+499% +$7.77K ﹤0.01% 1911
2024
Q1
$1.77K Sell
112
-495
-82% -$8.29K ﹤0.01% 1847
2023
Q4
$11K Buy
607
+495
+442% +$8.38K ﹤0.01% 1553
2023
Q3
$2K Hold
112
– – ﹤0.01% 1829
2023
Q2
$2K Sell
112
-66
-37% -$1.19K ﹤0.01% 1735
2023
Q1
$3K Buy
178
+54
+44% +$1.02K ﹤0.01% 1936
2022
Q4
$2K Buy
124
+12
+11% +$171 ﹤0.01% 1945
2022
Q3
$3K Hold
112
– – ﹤0.01% 1699
2022
Q2
$3K Buy
+112
New +$3K ﹤0.01% 1582

Other funds holding NEOG

Blue Trust's NEOG Position: Q3 2026 in Review

Blue Trust increased its Neogen (NEOG) stake by 356% in Q3 2026, buying an estimated $4.76K and bringing the position to 538 shares worth $6.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

Blue Trust first reported a position in NEOG in Q2 2022 and has held it in 18 quarters since. The position peaked at $57.2K in Q2 2025. 284 funds tracked by Wall St. Rank hold NEOG as of Q3 2026.

  • Blue Trust held 538 shares of Neogen worth $6.89K as of Q3 2026.
  • Blue Trust bought 420 Neogen shares in Q3 2026, an estimated $4.76K.
  • Neogen made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1789 holding.
  • Blue Trust first reported a position in Neogen in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Neogen position peaked at $57.2K in Q2 2025.
  • 284 funds tracked by Wall St. Rank held Neogen as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.